Amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig's disease, is a severe neurodegenerative disease that impacts nerve cells responsible for muscle movement, resulting in progressive muscle weakness and loss of the ability to move. The exact cause of ALS remains unknown, although a small number of cases are hereditary. When ALS begins, patients might experience tremors and weakness in the arms or legs, difficulties with swallowing, or slurred speech, which can progressively affect their ability to perform everyday functions such as walking, speaking, eating, and breathing.

According to the German Society for Muscle Diseases, ALS occurs when motor neurons in the brain and spinal cord become damaged or die. These neurons transmit signals from the nervous system to the muscles, allowing for movements like walking and chewing. As the disease progresses, patients may suffer a significant loss of motor functions, leading to profound physical limitations and increased dependence on caregivers. The lack of effective treatments intensifies the challenges faced by individuals diagnosed with this terminal condition, as there remains no known cure.

Medical professionals categorize different types of ALS and emphasize the variations in symptoms and progression rates among patients. This classification assists in understanding the disease's dynamics and guiding management strategies. As ALS continues to be a subject of research, enhanced awareness and education about the disease are critical for improving diagnostic and therapeutic approaches to support those affected.